Clinical Trial: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Clinical Study on the Efficacy and Safety of Tadalafil in Early Alzheimer's Disease (China)

China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Clinical Study on the Efficacy and Safety of Tadalafil in Early Alzheimer's Disease'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131266

Registration Time: 2026/08/31

Type: Interventional study

Primary Sponsor: Tongji Hospital of Tongji University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338196

Published by HT Digital Content Services with permission from Health Daily Digest....